AKA: (-)-BPAP, -)-1-(Benzofuran-2-yl)-2-propylaminopentane, or BFPAP
BPAP is a drug that was developed for use in delaying the onset/development of Parkinson's and Alzheimer's, similar to #deprenyl or #selegiline. It is available via clear net vendors.
BPAP is unique as it is a catecholamine activity enhancer; acting upon #serotonin#norepinephrine and #dopamine. This means it enhances the release of these #neurotransmitters in response to stimuli, as opposed to just causing an uncontrolled release as with #cocaine and #molly. It also exhibits #neuroprotective properties.
BPAP is similar to (-)deprenyl however it is #tryptamine derived as opposed to #phenylethylamine derived. It is more potent catecholamine enhancer but is also a much weaker inhibitor of MAO-A when compared to (-)deprenyl.